Newsletter Subject

Were you prescribed this for pain? Say no!

From

alsearsmd.com

Email Address

alsearsmd@send.alsearsmd.com

Sent On

Fri, Jul 12, 2024 03:51 PM

Email Preheader Text

Drug makers know that their antidepressant pills don’t work for most people with depression...

Drug makers know that their antidepressant pills don’t work for most people with depression... [Click here](1770d7/ct0_0/1/ms?sid=TV2%3Aj1hZ82vSf) to view this message in your browser | [Click here](1770d7/l-002e/zout?sid=TV2%3Aj1hZ82vSf) to stop receiving our messages [] [] Al Sears, MD 11905 Southern Blvd. Royal Palm Beach, FL 33411 [] July 12, 2024 [] Reader, Drug makers know that their antidepressant pills don’t work for most people with depression... And that the “chemical imbalance” theory related to low levels of brain serotonin has been thoroughly discredited.1 So they need a new use for the dozens of antidepressants currently on the market. It’s known as off-labeling – and it’s a common practice for drug makers and the doctors they influence. The latest example is prescribing depression medication as a “cure” for chronic pain. It’s an idea supported by some of the biggest names in mainstream medicine – including Harvard, the Mayo Clinic, Johns Hopkins, and the National Institutes of Health. The theory is that antidepressant drugs work by modulating chemicals in the brain, like serotonin and norepinephrine, which play a role in reducing pain perception. Increasing levels of these neurotransmitters disrupt pain signals sent by nerves. And that, say the drug makers, turns antidepressant medications into a powerful “weapon” that can block pain signaling pathways in the nervous system. So now, Big Pharma is pushing these potentially damaging drugs as an alternative to opioids. While I agree that it’s vital to offer patients alternatives to potentially addictive drugs, there’s a major problem with using antidepressants to cure chronic pain... They don’t work...and can cause more harm than good. A two-year review of more than 175 clinical trials analyzed the effects of various antidepressants on almost 30,000 participants who had three kinds of chronic pain: nerve pain, musculoskeletal pain, and fibromyalgia.2 As the lead study author put it, the review found “no reliable evidence for the long-term efficacy of any antidepressant and no reliable evidence for their safety for chronic pain at any point.” Of the 25 different depression drugs the study reviewed, only one – duloxetine – showed modest pain-relieving “promise.” That drug is duloxetine, sold under the brand name Cymbalta. Earlier research found that it provided a “small to moderate effect” on pain. But even these results are tainted because the study was sponsored by the pharmaceutical company that makes the drug! As a regular reader, you know that clinical trials sponsored by Big Pharma are more likely to have outcomes favoring the sponsor than were studies with other sponsors. But pain isn’t the only off-label use drug makers are trying to convince doctors to prescribe antidepressants for. Big Pharma wants you to take their antidepressants for: - Migraines - Attention-deficit/hyperactivity disorder (ADHD) - Peripheral neuropathy - Urinary incontinence - Hot flashes and night sweats - Obsessive-compulsive disorder - Gastroenterological conditions I don’t recommend antidepressants for pain or depression. They won’t improve your condition, and they come with a long list of nasty side effects including insomnia or difficulty staying awake… weight gain… sexual dysfunction… Confusion and dizziness… stroke and death.3,4,5,6,7,8 Try My 2-Pronged Natural Pain Prescription Treating your pain with any of Big Pharma’s drugs should be a last resort. Fortunately, there are safe, natural, and side-effect-free alternative ways to relieve pain. Here’s what I suggest you use instead: - Use the herbal pain reliever with no nasty side effects. The medicinal properties of CBD have been known since at least the ancient Egyptians. Today, studies prove that it’s a highly effective, drug-free, and affordable treatment for a wide variety of disorders, including depression and chronic pain. It not only works against pain, but it also attacks the inflammation at the source. Dozens of scientific studies prove it.9,10 One study examined more than 2,700 patients living with the chronic pain of fibromyalgia. After using CBD, around 40% of participants reported “much” or “very much” pain relief improvement. Another study by researchers at NYU Langone Health gave either CBD or a placebo to patients recovering from surgery. On the first few days after surgery, patients receiving CBD experienced, on average, 25% less pain compared to patients receiving a placebo. No major side effects were reported.12 You can buy CBD drops that are placed under the tongue or as a lotion made for local pain relief. For chronic pain, I recommend 20 mg of oral CBD twice daily. Increase the amount every three or four weeks until you get the necessary relief. - Try ashwagandha (especially for chronic arthritis pain): This “smart plant” is also called Indian ginseng and winter cherry. In a recent study, researchers gave 60 arthritis patients ashwagandha or a placebo. After 12 weeks, those taking the herb had significantly less pain, according to three different pain-score tests.13 I recommend 300 mg to 500 mg twice a day. Or you can buy dried ashwagandha root powder. Look for a product that’s 100% organic with no artificial flavors or colors. I like to add one teaspoon to a cup of boiling organic milk. I let it simmer for five minutes. Then I add a little honey to sweeten it. To Your Good Health, Al Sears, MD, CNS --------------------------------------------------------------- References: - Piore A. “Antidepressants work better than sugar pills only 15 percent of the time.” 2022. www.newsweek.com. Accessed on June 20, 2024. - Birkinshaw H, et al. “Antidepressants for pain management in adults with chronic pain: a network meta‐analysis.” Cochrane Database Syst Rev. 2023 May 10;5(5):CD014682. - Zhou S, et al. “Adverse effects of 21 antidepressants on sleep during acute-phase treatment in major depressive disorder: a systemic review and dose-effect network meta-analysis.” Sleep. 2023;46(10): zsad177 - Deshmukh R, Franco K. “Managing weight gain as a side effect of antidepressant therapy.” Cleve Clin J Med. 2003 Jul;70(7):614. - “King's study finds link between antidepressant use and weight gain.”www.kcl.ac.uk/kings-study-finds-link-between-antidepressant-use-and-weight-gain. Accessed on June 20, 2024. - Higgins A, et al. “Antidepressant-associated sexual dysfunction: impact, effects, and treatment.” Drug Health Patient Saf. 2010;2:141-150. - Juang H, et al. “Using antidepressants and the risk of stroke recurrence: report from a national representative cohort study.” [BMC Neurol.](1770d7/ct1_0/1/lu?sid=TV2%3Aj1hZ82vSf) 2015; 15: 86. - Smoller J, et al. “Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women’s Health Initiative Study.” Arch Intern Med. 2009; 169 (22): 2128-2139. - Canabo Medical Clinic. “5 health benefits of CBD.” Accessed on June 20, 2024. - Project CBD: Inflammation. Available at: . Accessed on June 20, 2024. - Boehnke K, et al. “Cannabidiol use for fibromyalgia: prevalence of use and perceptions of effectiveness in a large online survey.” J Pain. 2021 May;22(5):556-566. - Press Release. “Tablet containing cannabidiol shows promise in reducing postoperative pain.” Accessed on June 20, 2024. - Chopra A, et al. “Ayurveda–modern medicine interface: A critical appraisal of studies of Ayurvedic medicines to treat osteoarthritis and rheumatoid arthritis.” J Ayurveda Integr Med. 2010;1(3):190-198. alsearsmd@send.alsearsmd.com [Preferences | Unsubscribe](1770d7/l-002e/zout?sid=TV2%3Aj1hZ82vSf) 11905 Southern Blvd., Royal Palm Beach, Florida 33411, United States

Marketing emails from alsearsmd.com

View More
Sent On

08/12/2024

Sent On

05/12/2024

Sent On

04/12/2024

Sent On

30/11/2024

Sent On

29/11/2024

Sent On

28/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.